X0202 4 2007-09-12 0 0001333248 CADENCE PHARMACEUTICALS INC CADX 0001306133 ProQuest Investments III, L.P. 90 NASSAU STREET, 5TH FLOOR PRINCETON NJ 08542 0 0 1 0 0001033508 Moorin Jay C/O PROQUEST INVESTMENTS 90 NASSAU STREET, 5TH FLOOR PRINCETON NJ 08542-4520 0 0 1 0 0001225149 SCHREIBER ALAIN C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 1 0 1 0 Common Stock 2007-09-12 4 S 0 100 13.75 D 2922069 D Common Stock 2007-09-12 4 S 0 100 13.74 D 2921969 D Common Stock 2007-09-12 4 S 0 300 13.73 D 2921669 D Common Stock 2007-09-12 4 S 0 100 13.63 D 2921569 D Common Stock 2007-09-12 4 S 0 100 13.61 D 2921469 D Common Stock 2007-09-12 4 S 0 1 13.60 D 2921468 D Common Stock 2007-09-12 4 S 0 200 13.59 D 2921268 D Common Stock 2007-09-12 4 S 0 599 13.55 D 2920669 D Common Stock 2007-09-12 4 S 0 1000 13.50 D 2919669 D Common Stock 2007-09-14 4 S 0 500 13.50 D 2919169 D Dr. Alain Schreiber and Mr. Jay Moorin are managing members of ProQuest Associates III LLC and general partners of ProQuest Investments III, L.P. Dr. Schreiber and Mr. Moorin disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission for Section 16 or any other purpose. Hazel M. Aker Attorney-in-fact 2007-09-14